The cell signaling pathways that culminate in activation of a family of stress-activated MAP kinases are beginning to be de®ned. Determination of cell life and cell death is known to largely depend on the balance of intrinsic life and death signals within cells. Recently, two representative mammalian stress-activated kinases, the JNK and p38 MAP kinases, have been implicated in determination of cell fate by modifying the life, death and dierentiation signals. However, the molecular mechanisms by which extracellular signals are transmitted from membrane receptors to the most upstream kinases in the JNK and p38 signaling modules are not fully understood. This review will provide an overview of current knowledge of molecular links between in¯amma-tory cyokine receptors and stress-activated MAP kinase cascades.
Introduction
To date, over 30 proin¯ammatory cytokine receptors have been identi®ed, including the tumor necrosis factor (TNF) and Interleukin-1b (IL-1b) receptor superfamilies (Ashkenazi and Dixit, 1998; Baker and Reddy, 1998; Wallach et al., 1999) . Despite the absence of structural similarities between TNF and IL-1b receptors, ligand-induced activation of these receptors leads to overlapping, albeit non-identical, biological functions. One of the important as well as common events triggered by most of these in¯ammatory cytokine receptors is the activation of mitogenactivated protein (MAP) kinases and IkB kinases (IKKs), which ultimately activate various transcription factors such as activator protein 1(AP-1) (Brenner et al., 1989) and nuclear factor-kB (NF-kB) (Rothe et al., 1995a; Baeuerle and Baltimore, 1996; .
The MAP kinase signaling cascade is evolutionarily well conserved in cells from those of yeasts to humans and is typically composed of three hierarchical protein kinases including MAP kinase (MAPK), MAPK kinase (MAPKK) and MAPKK kinase (MAPKKK) (Errede and Levin, 1993; Davis, 1994; Waskiewicz and Cooper, 1995; Kyriakis and Avruch, 1996; Widmann et al., 1999; Schaeer and Weber, 1999) . MAPKKK phosphorylates and thereby activates MAPKK, and activated MAPKK in turn phosphorylates and activates MAPK. Activated MAPK then regulates the activities of transcription factors or kinases further downstream by phosphorylation, and thereby controls gene expression and cellular function.
In mammalian systems, at least six independent MAPK signaling units appear to function (Widmann et al., 1999; Schaeer and Weber, 1999) ; among them, the biochemical properties of three MAPKs, the extracellular signal-regulated kinases (ERKs), the c-Jun amino-terminal kinases (JNKs; also referred to as stress-activated protein kinases or SAPKs) and the p38 MAPKs (p38s), have been characterized in some detail. Unlike the ERK signaling pathway, the JNK and p38 pathways are not preferentially activated by mitogens but by in¯ammatory cytokines such as TNF and IL-1b and a diverse array of cellular stresses including UV light, X-rays, hydrogen peroxide (H 2 O 2 ), heat and osmotic shock, and withdrawal of growth factors. Although many JNK/p38-activating stimuli are proapoptotic, the biological outcome of JNK/p38 activation is highly divergent and appears to be largely dependent on cell type or cellular context. This review will mainly consider what is known about mechanisms of signaling from TNF, lL-1 and Fas receptors to JNKs and p38s cascades.
Upstream kinases in the JNK and p38 modules
In the JNK subgroup, three genes (jnk1, jnk2 and jnk3) and ten dierent splicing variants have been described (Gupta et al., 1996; Widmann et al., 1999) . JNKs are activated by two distinct MAPKKs, MKK4/SEK1 (Sanchez et al., 1994; Derijard et al., 1995) , and MKK7 Yao et al., 1997; Wu et al., 1997; Tournier et al., 1997; Holland et al., 1997) , in the JNK signaling unit. The p38 subgroup is composed of four genes including p38a, p38b, p38g and p38d (Han et al., 1994; Lee et al., 1994; Jiang et al., 1997; Stein et al., 1997; Goedert et al., 1997; Wang et al. 1997) . The p38s are also activated by at least two MAPKKs, MKK3 and MKK6 (Stein et al., 1996; Moriguchi et al., 1996) . Notably, MKK4 is also an activator of p38s at least in vitro . In contrast to MAPKs and MAPKKs, the MAPKKKs in the JNK and p38 modules are highly divergent in structure and gene number. To date, eleven dierent MAPKKKs have been identi®ed as upstream activators of JNK pathway (Widmann et al., 1999) ; MEKK1 (Lange et al., 1993) , MEKK2 (Blank et al., 1996) , MEKK3 (Blank et al., 1996) , MTK1/ MEKK4 (Takekawa et al., 1997; Gerwins et al., 1997) , Tpl-2/Cot (Aoki et al., 1991; Salmeron et al., 1996) , MUK/DLK/ZPK Holzman et al., 1994; Reddy and Pleasure, 1994) , MLK-2/MST (Dorow et al., 1995; Hirai et al., 1997) , MLK-3/SPRK/ PTK-1 (Rana et al., 1996; Gallo et al., 1994; Ing et al., 1994) , TAK1 (Yamaguchi et al., 1995) , ASK1/ MAPKKK5 Ichijo et al., 1997) and ASK2 (Saitoh and Ichijo, unpublished observation)/MAPKKK6 (Wang et al., 1998) have been shown to activate JNKs by overexpression (Figure 1 ). Of these, MEKK1, MEKK2, MEKK3 and Tpl-2 can also activate the ERK pathway, while only TAK1, ASK1 and MTK1 have been shown to strongly activate p38s as well. There are no known MAPKKKs which activate only p38s or p38s and the ERKs pathways. In addition, genetic evidence from yeast and¯ies suggests that a group of kinases which appear to function upstream of MAPKKKs may exist in certain MAPK modules (Widmann et al., 1999; Kyriakis, 1999) , despite the lack of direct biochemical evidence that these kinases activate MAPKKK by phosphorylation. Thus, at least 14 dierent but structurally related kinases in this group are suggested to function as mammalian MAPKKKKs, including PAK1, 2, 3 and 4 (Manser et al., 1994; Knaus et al., 1995; Abo, 1998) , GCK (Katz et al., 1994) , GCKR/KHS (Shi and Kehrl, 1997; Tung and Blenis, 1997) , GLK , HPK1 (Kiefer et al., 1996; Hu et al., 1996) , NIK (Nck-interacting kinase)/HGK (Su et al. 1997; Yao et al. 1999) , SOK1 (previously called UK-1; Pombo et al., 1996) , Krs-1 (Taylor et al., 1996) , MST1/Krs-2(Creasy and Cherno, 1995; Taylor et al., 1996) , MST3 (Schinkmann and Blenis, 1997) and LOK (Kuramochi et al., 1997) . Most of the MAPKKKKs, but not SOK1, Krs-1, MST3 and LOK, can activate JNK by overexpression. MST1 activates both JNK and p38 through MKK7 and MKK6 (Graves et al., 1998) , respectively. The numbers of MAPKKKs and MAPKKKKs are much larger than those of MAPKKs and MAPKs. This raises the question why so many MAPKKKs and MAPKKKKs exist. A likely answer is that these upstream kinases have unique substrates which do not belong to the MAPK modules. In fact, MEKK1 (Nakano et al., 1998), MEKK2 and 3 (Zhao and Lee, 1999) , Tpl2 (Belich et al., 1999; Lin et al., 1999) and TAK1 (Ninomiya-Tsuji et al., 1999) can also activate NF-kB by phosphorylating certain components in this pathway. Alternatively, the divergence of upstream kinases may be utilized by cells to discriminate and dierentially respond to a wide variety of extracellular stimuli such as growth factors, cytokines and physicochemical stressors.
Shuttles from receptors to MAPKKK
A number of molecules have been implicated in the coupling between MAPKKKs and membrane receptors for in¯ammatory cytokines, ranging from adaptor proteins, scaold proteins, MAPKKKKs and small GTPases to caspases.
TNF receptor associated factors (TRAFs)
TNF signals are mediated by two cell surface receptors, TNF receptor (TNFR)-1 and TNFR-2 (Tartaglia and Goeddel, 1992) . TNF binding induces receptor aggregation, which results in the recruitment of a number of cytoplasmic signaling proteins to two distinct TNFR complexes (Rothe et al., 1994 (Rothe et al., , 1995b Hsu et al., 1995 Hsu et al., , 1996a Shu et al., 1996) . One of these molecules is TNF receptor associated factor 2 Figure 1 The mammalian stress-activated MAP kinase modules. The question marks indicate that direct evidence of these pathways remain to be established (TRAF2), which interacts directly with TNFR-2 (Rothe et al., 1994) but is recruited to TNFR-1 via its interaction with TNFR-1-associated death domain protein (TRADD; Hsu et al., 1995 Hsu et al., , 1996b . To date, six members of the TRAF family have been identi®ed (Hu et al., 1994; Rothe et al., 1994; Cheng et al., 1995; Mosialos et al., 1995; ReÂ gnier et al., 1995; Cao et al., 1996; Nakano et al., 1996) . All TRAFs contain a conserved C-terminal TRAF domain that is used for homo-or hetero-oligomerization and for interaction with the cytoplasmic regions of the TNFR superfamily. With the exception of TRAF1, all TRAF proteins contain an N-terminal Ring ®nger and several zinc ®nger structures that are critical for their eector functions (Hu et al., 1994; Rothe et al., 1994; Cheng et al., 1995; Mosialos et al., 1995; ReÂ gnier et al., 1995; Cao et al., 1996; Nakano et al., 1996) . Structural and biochemical analyses suggest that TRAFs do not possess enzymatic activity, in turn suggesting that they function as adaptor proteins.
Overexpression studies have implicated TRAF2 in TNF-induced activation of JNK, p38 and NF-kB (Rothe et al., 1995a; Hsu et al., 1996b; Liu et al., 1996; Takeuchi et al., 1996; Natoli et al., 1997; Reinhard et al., 1997) . NF-kB-inducing kinase (NIK; note: dierent from MAPKKKK NIK noted above) is a MAPKKK-related protein kinase that associates with TRAF2 and other members of the TRAF family and mediates activation of NF-kB through IKKs but does not activate JNK or p38 (Song et al., 1997) . On the other hand, TRAF2-mediated activation of JNK can be inhibited by catalytically inactive mutants of MEKK1, ASK1, GCK or GCKR (see below). Consistent with the results of overexpression studies using a dominant-negative (DN)-TRAF2 mutant (deletion mutant of N-terminal Ring domain) which inhibits TNF-but not IL-1-induced JNK and NF-kB activation, TNF signaling to JNK is greatly reduced in TRAF2-de®cient cells (Yeh et al., 1997) . However, TNF-induced NF-kB activity was only marginally, if at all, aected in TRAF27/7 cells, suggesting that other members of the TRAF protein family may function in this pathway. Among TRAFs, only TRAF2, TRAF5 and TRAF6 have been shown to activate JNK and NF-kB. Recent gene targetting studies of TRAF6 found that IL-1-, CD-40-and LPS-but not TNF-induced NF-kB activity was impaired in TRAF67/7 cells (Lomaga et al., 1999) . IL-1-induced JNK was also undetectable in these cells, clearly indicating that TRAF6 is required for IL-1-mediated JNK and NF-kB activation but not TNFinduced activation of NF-kB. The traf5 gene was also very recently disrupted in mice (Nakano et al., 1999) , and TNF-induced activation of NF-kB was not abrogated in TRAF57/7 cells. These ®ndings suggest that yet another unidenti®ed TRAF or TRAF-independent mechanism may be operating in the TNF-induced NF-kB pathway. In this context, receptor interacting protein (RIP), a death domaincontaining serine/threonine kinase, may be an important candidate as a signaling intermediate in this pathway; RIP interacts with TNFR-1 via TRADD in a TNF-dependent manner, and RIP7/7 cells are defective in TNF-induced NF-kB but not JNK activation (Ting et al., 1996; Kelliher et al., 1998) . Although RIP also interacts with TRAF2, TRADD-RIP interaction might skip TRAF2 and be sucient to activate downstream component(s), e.g., NIK ( Figure  2 ). Additional studies are required to determine the TNF-induced NF-kB signaling pathway in detail.
How does TRAF2 activate JNKs and p38s? As noted above, two MAPKKKs, ASK1 and MEKK1, Figure 2 Overview of life and death signaling cascades of proin¯ammatory cytokines Stress activated kinases H Ichijo are strong candidates for bridging the gap in this pathway. ASK1 activates both the MKK4/MKK7-JNKs and MKK3/MKK6-p38s signaling cascades in vitro and in vivo (Ichijo et al., 1997; our unpublished observation) . Overexpression of ASK1 in Mv1Lu mink epithelial cells under low-serum conditions induces apoptosis, and a kinase-inactive mutant of ASK1 reduces TNF-induced apoptosis, suggesting a role for ASK1 in the TNF signaling pathway leading to apoptosis (Ichijo et al., 1997) . ASK1 was subsequently found to directly bind TRAF family proteins, including TRAF1, TRAF2, TRAF3, TRAF5 and TRAF6 by overexpression . ASK1 can be activated by TRAF2, TRAF5 and TRAF6 but not by other TRAFs. DN-TRAF2 blocks TNF-induced ASK1 activation, and a kinase-inactive mutant of ASK1 strongly inhibits TNF-and TRAF2-induced JNK activation. Importantly, in untransfected cells ASK1 associates with TRAF2 in a TNFdependent manner . This interaction can be observed transiently after TNF treatment, consistent with the time course of TNFinduced kinase activation of ASK1 (Ichijo et al., 1997) . ASK1 is thus a direct downstream target of TRAF2. While IL-1 and H 2 O 2 Gotoh and Cooper, 1998 ) also activate ASK1, TRAF2-ASK1 interaction cannot be induced by these stimuli, suggesting that recruitment of ASK1 to the active TRAF2 components may be a speci®c mechanism by which TNF activates both the ASK1-JNKs and ASK1-p38s axes.
TRAF2 also signals to JNK through MEKK1 (Shi and Kehrl, 1997; Baud et al. 1999) . Recently, the Nterminal RING domain (Baud et al. 1999 ) and Cterminal TRAF domain (Yuasa et al., 1998; Kyriakis, 1999) of TRAF2 have been shown to physically interact with MEKK1 and GCK/GCKR, respectively. Moreover, the C-terminal non-catalytic fragment of GCK can interact with the N-terminal non-catalytic domain of MEKK1 (residues 871 ± 1221) and activate the kinase activity of MEKK1 (Yuasa et al., 1998) . Although full-length GCK can also phosphorylate MEKK1(871 ± 1221), direct evidence of phosphorylation-dependent activation of MEKK1 by GCK/GCKR family members has not yet been addressed. DNmutants of MEKK1 and GCKR block TNF-and TRAF2-induced activation of JNK, and DN-MEKK1 blocks GCK-induced JNK (Yuasa et al., 1998) . Thus, GCK and GCKR appear to serve as molecular bridges coupling TRAF2 to MEKK1 via direct and/or indirect interaction. TNF-induced ternary complex formation of TRAF2-GCK/GCKR-MEKK1 will be interesting to study. Importantly, however, TNF treatment or TRAF2 overexpression induces not only JNK but also p38 activity. Since MEKK1 and GCK/GCKR can activate only JNK, ASK1 is likely to be a physiological target of TRAF2 in recruiting p38. TAK1 is also activated by TNF (Shirakabe et al., 1997) and IL-1 (Ninomiya-Tsuji et al., 1999) , and overexpression of TAK1 is capable of activating JNKs/p38s as well as the NF-kB pathway. Recently, TAK1 was clearly demonstrated to associate with TRAF6 in an IL-1-dependent manner. However, since TAK1 does not interact with TRAF2 (Ninomiya-Tsuji et al., 1999) , it may have a speci®c function in IL-1-but not TNFinduced JNK/p38 activity.
Thioredoxin (Trx) as a negative regulator of ASK1-JNK axis
Another important mechanism of TNF-induced JNK pathway has emerged from yeast two-hybrid screening for ASK1-binding proteins; thioredoxin (Trx) was identi®ed as a negative regulator of the ASK1-JNK pathway . Thus, in unstimulated cells, ASK1 is present as an inactive complex with Trx. Interestingly, only a reduced form of Trx associates with the N-terminal regulatory domain of ASK1 and keeps ASK1 kinase inactive. Upon treatment of cells with TNF or reactive oxygen species (ROS) such as H 2 O 2 , Trx appears to be oxidized and unbound from ASK1, enabling activation of ASK1 . Trx thus appears to act as a physiological inhibitor of TNF-and ROS-induced activation of ASK1. Importantly, overexpression of Trx in excess of coexpressed TRAF2 inhibits the TRAF2-ASK1 interaction, while overexpression of wild-type TRAF2 but not DN-TRAF2 removes coexpressed Trx from the ASK1-Trx complex (Liu et al., submitted for publication). Generation of ROS appears to be required for TRAF2 to inactivate Trx and thereby bind to and activate ASK1. TNF-induced ASK1 activity may thus be regulated within cells by at least two distinct adaptor molecules positively (TRAF2) and negatively (Trx).
TRAF2-GCK/GCKR-MEKK1 constitutes an ASK1-independent signaling pathway to JNK activation. The functional signi®cance of these two pathways is unclear; however, they may be independently and dierentially used to enable TNF to confer dierential intensity or duration of JNK signals. In fact, while TNF-induced kinase activity of GCKR peaks within 10 min after TNF treatment (Shi and Kehrl, 1997) , that of ASK1 peaks at 30 min and is sustained to some extent (Ichijo et al., 1997) . Alternatively, dierent cells may distinctly respond to TNF by recruiting either pathway.
Small G proteins
Activation of JNKs and p38s can also be induced by the activation of small G proteins of the Rho family (Bagrodia et al. 1995) . Constitutively active forms of these proteins, in particular Rac and Cdc42, strongly activate JNKs and p38s by overexpression. DNmutants of Rac and Cdc42 inhibit IL-1-induced JNK/p38 activation, suggesting that these small G proteins may mediate IL-1 signals to upstream kinase(s) in JNK/p38 modules. Of the MAPKKKKs and MAPKKKs, PAKs, MEKK1 (Fanger et al., 1997) , MTK1/MEKK4 (Gerwins et al., 1997) , MLK2 and MLK3 (Nagata et al., 1998) have been shown to bind Rac and Cdc42 in their Cdc42/Rac GTPase-binding (CRIB) domains. MTK4/MEKK1 has also been shown to bind and thereby get activated by a family of GADD45 proteins, which are not small G proteins but genotoxic stress-induced proteins (Takekawa and Saito, 1998) . Further studies will be needed to determine the functional signi®cance of small G proteins in cytokine-induced JNK/p38 activity.
Stress activated kinases H Ichijo
Scaold proteins ®lling the gap?
Targeting of certain receptor signals to speci®c MAPK modules may be regulated by the presence of scaold proteins which facilitate the assembly of regulatoreector complexes by increasing the local concentration of cascade components (Whitmarsh and Schaeer and Weber, 1999) . Examples of this have been identi®ed in S. cerevisiae, and recently in mammals (Schaeer et al., 1998; Whitmarsh et al., 1998) . JNK interacting protein (JIP1) selectively binds to MKK7 (MAPKK), MLK3 (MAPKKK) and HPK (MAPKKKK), thereby enhances the eciency and speci®city of enzyme-substrate interactions (Whitmarsh et al., 1998) . Although no scaold proteins that directly interact with cytokine receptors have thus far been identi®ed, such a mechanism would not only enhance signaling eciency but also greatly insulate the corresponding MAPK module against unnecessary cross-talk.
JNK pathways in cytokine-induced apoptosis
Fas belongs to a family of death receptors, including TNFR-1, DR3, 4 and 5, which induces cell death upon oligomerization (Ashkenazi and Dixit, 1998; Nagata, 1997) . Activated Fas recruits FADD and thereby activates caspase-8, which proteolytically activates caspases further downstream, leading to apoptosis. Caspases can cleave not only their death substrates but a variety of signal transduction components including upstream kinases in the JNK/p38 cascades. They include PAK2 (Rudel and Bokoch, 1997), MST1 (Graves et al., 1998) and MEKK1 (Cardone et al., 1997) which are activated upon cleavage of their regulatory domains by caspases. Although the functional signi®cance of activation of these kinases is still unclear, it is suggested that caspase-mediated activation of these kinases may enhance apoptosis and mediate certain phenotypes of apoptotic cells in a JNKdependent and -independent manners, respectively. In addition to the caspase-mediated activation of JNK, Fas can enhance apoptosis in certain types of cells, by activating a second pathway which involves another Fas adaptor protein, Daxx . Daxx binds to the N-terminal noncatalytic domain of ASK1 upon Fas-stimulation and thereby activates JNKs which may sensitize cells to caspase-induced apoptosis (Chang et al., 1998) . Importantly, however, the eects of DN-Daxx and DN-ASK1 in inhibiting Fas-induced apoptosis are much weaker than those of caspase inhibitors. How the Daxx-ASK1-JNK axis confers susceptibility to Fas-induced apoptosis thus remains an important question. Moreover, TRAF27/7 cells which are defective in TNF-induced JNK activity have been reported to be more susceptible to TNF-induced apoptosis than wild-type cells (Yeh et al., 1997) , indicating that TRAF2-mediated JNK activity is antiapoptoic. On the other hand, DN-TRAF2 transgenic mice developed splenomegaly and lymphadenopathy, suggesting that TRAF2 may also possess proapoptotic activity (Lee et al., 1997) . In fact, overexpression of TRAF2 is cytotoxic in certain cell types including Hela cells (our unpublished data). Further study will be required to elucidate in detail roles played by JNKs/p38s in cytokine-induced apoptosis. Figure 2 summarizes the representative downstream components of the TNF, Fas and IL-1 receptors. Ceramides and certain phosphatases have also been suggested to play signi®cant roles in signaling mechanisms from receptors to JNKs/p38s, albeit their direct molecular targets are unknown. Understanding the physiological roles of such signaling intermediates will further disclose the precise regulatory mechanisms of these kinase cascades. MAPKKKKs and MAPKKKs may have their unique substrates which do not belong to the MAPKKK-MAPKK-MAPK cascade. Identi®cation of such molecules should resolve a number of questions of how and why cytokines control a wide variety of cellular functions through these kinases.
Concluding remarks

